Venrock Healthcare Capital Partners III, L.P. 13D and 13G filings for ARCA biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-04-29 7:28 pm Purchase | 2024-04-17 | 13G | ARCA biopharma, Inc. ABIO | Venrock Healthcare Capital Partners III, L.P. | 62,889 5.200% | 62,889 (New Position) | Filing |